NZ Herald
  • Home
  • Latest news
  • Herald NOW
  • Video
  • New Zealand
  • Sport
  • World
  • Business
  • Entertainment
  • Podcasts
  • Quizzes
  • Opinion
  • Lifestyle
  • Travel
  • Viva
  • Weather

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • New Zealand
    • All New Zealand
    • Crime
    • Politics
    • Education
    • Open Justice
    • Scam Update
  • Herald NOW
  • On The Up
  • World
    • All World
    • Australia
    • Asia
    • UK
    • United States
    • Middle East
    • Europe
    • Pacific
  • Business
    • All Business
    • MarketsSharesCurrencyCommoditiesStock TakesCrypto
    • Markets with Madison
    • Media Insider
    • Business analysis
    • Personal financeKiwiSaverInterest ratesTaxInvestment
    • EconomyInflationGDPOfficial cash rateEmployment
    • Small business
    • Business reportsMood of the BoardroomProject AucklandSustainable business and financeCapital markets reportAgribusiness reportInfrastructure reportDynamic business
    • Deloitte Top 200 Awards
    • CompaniesAged CareAgribusinessAirlinesBanking and financeConstructionEnergyFreight and logisticsHealthcareManufacturingMedia and MarketingRetailTelecommunicationsTourism
  • Opinion
    • All Opinion
    • Analysis
    • Editorials
    • Business analysis
    • Premium opinion
    • Letters to the editor
  • Politics
  • Sport
    • All Sport
    • OlympicsParalympics
    • RugbySuper RugbyNPCAll BlacksBlack FernsRugby sevensSchool rugby
    • CricketBlack CapsWhite Ferns
    • Racing
    • NetballSilver Ferns
    • LeagueWarriorsNRL
    • FootballWellington PhoenixAuckland FCAll WhitesFootball FernsEnglish Premier League
    • GolfNZ Open
    • MotorsportFormula 1
    • Boxing
    • UFC
    • BasketballNBABreakersTall BlacksTall Ferns
    • Tennis
    • Cycling
    • Athletics
    • SailingAmerica's CupSailGP
    • Rowing
  • Lifestyle
    • All Lifestyle
    • Viva - Food, fashion & beauty
    • Society Insider
    • Royals
    • Sex & relationships
    • Food & drinkRecipesRecipe collectionsRestaurant reviewsRestaurant bookings
    • Health & wellbeing
    • Fashion & beauty
    • Pets & animals
    • The Selection - Shop the trendsShop fashionShop beautyShop entertainmentShop giftsShop home & living
    • Milford's Investing Place
  • Entertainment
    • All Entertainment
    • TV
    • MoviesMovie reviews
    • MusicMusic reviews
    • BooksBook reviews
    • Culture
    • ReviewsBook reviewsMovie reviewsMusic reviewsRestaurant reviews
  • Travel
    • All Travel
    • News
    • New ZealandNorthlandAucklandWellingtonCanterburyOtago / QueenstownNelson-TasmanBest NZ beaches
    • International travelAustraliaPacific IslandsEuropeUKUSAAfricaAsia
    • Rail holidays
    • Cruise holidays
    • Ski holidays
    • Luxury travel
    • Adventure travel
  • Kāhu Māori news
  • Environment
    • All Environment
    • Our Green Future
  • Talanoa Pacific news
  • Property
    • All Property
    • Property Insider
    • Interest rates tracker
    • Residential property listings
    • Commercial property listings
  • Health
  • Technology
    • All Technology
    • AI
    • Social media
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology
    • Opinion
    • Audio & podcasts
  • Weather forecasts
    • All Weather forecasts
    • Kaitaia
    • Whangārei
    • Dargaville
    • Auckland
    • Thames
    • Tauranga
    • Hamilton
    • Whakatāne
    • Rotorua
    • Tokoroa
    • Te Kuiti
    • Taumaranui
    • Taupō
    • Gisborne
    • New Plymouth
    • Napier
    • Hastings
    • Dannevirke
    • Whanganui
    • Palmerston North
    • Levin
    • Paraparaumu
    • Masterton
    • Wellington
    • Motueka
    • Nelson
    • Blenheim
    • Westport
    • Reefton
    • Kaikōura
    • Greymouth
    • Hokitika
    • Christchurch
    • Ashburton
    • Timaru
    • Wānaka
    • Oamaru
    • Queenstown
    • Dunedin
    • Gore
    • Invercargill
  • Meet the journalists
  • Promotions & competitions
  • OneRoof property listings
  • Driven car news

Puzzles & Quizzes

  • Puzzles
    • All Puzzles
    • Sudoku
    • Code Cracker
    • Crosswords
    • Cryptic crossword
    • Wordsearch
  • Quizzes
    • All Quizzes
    • Morning quiz
    • Afternoon quiz
    • Sports quiz

Regions

  • Northland
    • All Northland
    • Far North
    • Kaitaia
    • Kerikeri
    • Kaikohe
    • Bay of Islands
    • Whangarei
    • Dargaville
    • Kaipara
    • Mangawhai
  • Auckland
  • Waikato
    • All Waikato
    • Hamilton
    • Coromandel & Hauraki
    • Matamata & Piako
    • Cambridge
    • Te Awamutu
    • Tokoroa & South Waikato
    • Taupō & Tūrangi
  • Bay of Plenty
    • All Bay of Plenty
    • Katikati
    • Tauranga
    • Mount Maunganui
    • Pāpāmoa
    • Te Puke
    • Whakatāne
  • Rotorua
  • Hawke's Bay
    • All Hawke's Bay
    • Napier
    • Hastings
    • Havelock North
    • Central Hawke's Bay
    • Wairoa
  • Taranaki
    • All Taranaki
    • Stratford
    • New Plymouth
    • Hāwera
  • Manawatū - Whanganui
    • All Manawatū - Whanganui
    • Whanganui
    • Palmerston North
    • Manawatū
    • Tararua
    • Horowhenua
  • Wellington
    • All Wellington
    • Kapiti
    • Wairarapa
    • Upper Hutt
    • Lower Hutt
  • Nelson & Tasman
    • All Nelson & Tasman
    • Motueka
    • Nelson
    • Tasman
  • Marlborough
  • West Coast
  • Canterbury
    • All Canterbury
    • Kaikōura
    • Christchurch
    • Ashburton
    • Timaru
  • Otago
    • All Otago
    • Oamaru
    • Dunedin
    • Balclutha
    • Alexandra
    • Queenstown
    • Wanaka
  • Southland
    • All Southland
    • Invercargill
    • Gore
    • Stewart Island
  • Gisborne

Media

  • Video
    • All Video
    • NZ news video
    • Herald NOW
    • Business news video
    • Politics news video
    • Sport video
    • World news video
    • Lifestyle video
    • Entertainment video
    • Travel video
    • Markets with Madison
    • Kea Kids news
  • Podcasts
    • All Podcasts
    • The Front Page
    • On the Tiles
    • Ask me Anything
    • The Little Things
  • Cartoons
  • Photo galleries
  • Today's Paper - E-editions
  • Photo sales
  • Classifieds

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In
Advertisement
Advertise with NZME.
Home / World

Explained: The malaria drug Trump is using to fight Covid-19

By Gavin Fernando
news.com.au·
20 May, 2020 01:35 AM7 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

Hydrochloroquine has raised concerns among health experts as a Covid-19 cure. Photo / AP

Hydrochloroquine has raised concerns among health experts as a Covid-19 cure. Photo / AP

Donald Trump raised eyebrows on Tuesday after revealing he takes hydroxychloroquine, a medication he has touted as a "miracle drug" for curing Covid-19.

The President said he had started taking the drug "a couple of weeks ago", despite warnings from doctors.

The drug has raised concerns among health experts, and numerous studies have found it to be ineffective at treating Covid-19 – as well as potentially dangerous.

READ MORE:
• Covid 19 coronavirus: Trump sends White House scrambling to justify anti-malaria drug
• Covid-19 coronavirus: More deaths, no benefit from malaria drug in study
• Covid 19 coronavirus: White House pushes unproven malaria drug for virus
• Covid-19 coronavirus: Heart woes spur partial stop of malaria drug study for virus

Fox News host, Neil Cavuto, warned viewers not to follow the president's example as it could have deadly consequences.

Advertisement
Advertise with NZME.
Advertisement
Advertise with NZME.

"If you are in a risky population here, and you are taking this as a preventive treatment to ward off the virus — or, in a worst case scenario you are dealing with the virus and you are in this vulnerable population — it will kill you," Cavuto said.

"I cannot stress this enough. This will kill you."

The TV host cited a recent study into using hydroxychloroquine as a preventive or treatment for Covid-19 which found that there was benefit using the drug in that way and that it could actually be harmful.

Advertisement
Advertise with NZME.

Fox News's Neil Cavuto is stunned by Trump's announcement that he's taking hydroxychloroquine: "If you are in a risky population here, and you are taking this as a preventative treatment ... it will kill you. I cannot stress enough. This will kill you." pic.twitter.com/e6D5alfAgc

— Aaron Rupar (@atrupar) May 18, 2020

"Whatever benefits the president says this (drug) has, this is a leap that should not be taken casually by those watching at home saying 'well, the President of the United States says it's okay'," Cavuto said.

WHAT IS HYDROXYCHLOROQUINE?

Hydroxychloroquine is a drug commonly used at low doses to help people suffering from rheumatoid arthritis and lupus.

The medicine was originally developed to treat malaria.

But since 2006, it has not been recommended for use in severe malaria due to resistance issues, according to the World Health Organisation.

Discover more

World

Trump unleashes on China's 'incompetence'

20 May 10:11 PM

WHAT HAS TRUMP SAID ABOUT IT?

In April, Trump hailed hydroxychloroquine as a "miracle drug" after a single French study claimed it was a potential coronavirus cure.

"What do you have to lose?" he said during a coronavirus briefing last month. "I'm not looking at it one way or another. If it does work, it would be a shame if we didn't do it early. But what do I know, I'm not a doctor. But I have common sense."

WHY IS TRUMP TAKING IT?

Yesterday, Trump revealed he is taking the drug hydroxychloroquine, despite health warnings.

"A lot of good things have come out about the hydroxy. A lot of good things have come out," Trump told reporters at the White House.

President Donald Trump revealed he is taking the drug hydroxychloroquine, despite health warnings from doctors. Photo / AP
President Donald Trump revealed he is taking the drug hydroxychloroquine, despite health warnings from doctors. Photo / AP

"And you'd be surprised at how many people have taken it, especially the frontline workers, before you catch it. The frontline workers, many many are taking it.

"I happen to be taking it. I happen to be taking it. I'm taking it, hydroxychloroquine. Right now, yeah."

Advertisement
Advertise with NZME.

The President said he had started taking the drug "a couple of weeks ago".

"Because I think it's good. I've heard a lot of good stories. And if it's not good, I'll tell you. I'm not going to get hurt by it. It's been around for 40 years, for malaria, for lupus, for other things," he said.

"I take it. Frontline workers take it. Lots of doctors take it. I take it. You know, I hope to not be able to take it soon, because I hope they come up with some answer. But I think people should be allowed to."

WHAT ARE THE DANGERS OF IT?

Doctors quickly warned that hydroxychloroquine can have severe side effects in some situations, including death.

• Covid19.govt.nz: The Government's official Covid-19 advisory website

Common side effects include headaches, nausea, vomiting and diarrhoea. In rarer cases users can experience stomach pain, loss of appetite and weight loss, irritability, skin rashes or itching, and hair loss.

Advertisement
Advertise with NZME.

Subsequent studies have suggested the drug is not effective at treating the virus, and might even increase patients' risk of dying.

BUT DIDN'T THAT FRENCH STUDY SAY IT WAS LEGITAMATE?

In early March, a group of scientists in the southern French city of Marseilles launched an experiment to see if hydroxychloroquine could cure Covid-19.

Before the results had even been published, Gregory Rigano, a lawyer who claimed to be affiliated with the Stanford University of Medicine, publicly declared the results a "100 per cent cure rate against coronavirus".

Shortly afterwards, Trump hailed the drug as a "game-changer".

But here's the kicker: Stanford later revealed that Rigano had no affiliation with the school. His endorsement was null and void.

Hydrochloroquine has raised concerns among health experts as a Covid-19 cure. Photo / AP
Hydrochloroquine has raised concerns among health experts as a Covid-19 cure. Photo / AP

Experts have since concluded the Marseilles study was too small and lacked the detail and rigour to be classed as evidence of a legitimate treatment.

Advertisement
Advertise with NZME.

Any drug being used as a cure for a virus before full clinical trials have been completed is, by definition, untested and unproven.

Two weeks after the study was first published online, the International Society of Antimicrobial Chemotherapy, which publishes the IJAA, disputed the results.

"The ISAC Board believes the article does not meet the Society's expected standard, especially relating to the lack of better explanations of the inclusion criteria and the triage of patients to ensure patient safety," it said in a statement.

France's own Health Minister, Olivier Véran, said it shouldn't be used by anyone with the exception of "serious forms of hospitalisation and on the collegial decision of doctors and under strict medical supervision".

OK, SO WHAT DOES THE OTHER RESEARCH SAY?

America's Food and Drug Administration has cautioned against its use for coronavirus outside of a hospital setting or clinical trial, as it can cause "serious heart rhythm problems" and "a dangerously rapid heart rate".

Last month, an American study was conducted at a hospital for veterans, with 368 male patients.

Advertisement
Advertise with NZME.

According to the study, 28 per cent of the veterans who were given hydroxychloroquine plus routine care died, compared to 11 per cent of those getting routine care alone.

And 22 per cent who received both hydroxychloroquine plus the antibiotic azithromycin died, though researchers said the difference between the group and usual care was significant.

Hydroxychloroquine made no difference in preventing needs for a ventilator.

Studies in other countries have yielded similar results. A small French study, led by Jean-Michel Molina and conducted in a hospital in Paris, found hydroxychloroquine reduced neither deaths nor ICU admissions among patients who received it.

Their study found that after five to six days of treatment with hydroxychloroquine and azithromycin, eight of their 10 patients still tested positive for COVID-19. One patient died, two were transferred to the ICU and another had to be removed from the treatment due to serious complications.

A Brazilian study, published in the Journal of the American Medical Association Network Open (Jama), was shut down after two deaths and heart problems among patients who were given a high dose of chloroquine, a drug in the same family as hydroxychloroquine.

Advertisement
Advertise with NZME.

A Chinese study showed patients who received the drug didn't recover any faster or better than patients who didn't get the drug.

Another hydroxychloroquine study is currently taking place on 20 patients at Upstate University Hospital in Syracuse, USA. Chief of infectious diseases Dr Stephen Thomas said researchers hope to know within a few weeks "if it's safe and has a clinical benefit".

ARE THERE ANY OTHER SIDE EFFECTS?

One rare potential side effect of the drug, particularly when taken in conjunction with azithromycin, can be ventricular arrhythmia, which in some patients can prove fatal. A rare side effect means it occurs between one in 1000 and one in 10,000 cases.

Save

    Share this article

Latest from World

World

Haifa under fire: 19 injured as Iran launches latest missile barrage

20 Jun 06:59 PM
World

Israel strikes dozens of Tehran targets in aggressive overnight raids

20 Jun 08:29 AM
World

Trump to decide on Iran invasion within two weeks

Jono and Ben brew up a tea-fuelled adventure in Sri Lanka

sponsored
Advertisement
Advertise with NZME.

Latest from World

Haifa under fire: 19 injured as Iran launches latest missile barrage

Haifa under fire: 19 injured as Iran launches latest missile barrage

20 Jun 06:59 PM

Iran urged to continue diplomacy even as bombing continues.

Israel strikes dozens of Tehran targets in aggressive overnight raids

Israel strikes dozens of Tehran targets in aggressive overnight raids

20 Jun 08:29 AM
Trump to decide on Iran invasion within two weeks

Trump to decide on Iran invasion within two weeks

Tensions rise: Hospital, nuclear sites targeted in Iran-Israel conflict

Tensions rise: Hospital, nuclear sites targeted in Iran-Israel conflict

20 Jun 06:49 AM
Help for those helping hardest-hit
sponsored

Help for those helping hardest-hit

NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • NZ Herald e-editions
  • Daily puzzles & quizzes
  • Manage your digital subscription
  • Manage your print subscription
  • Subscribe to the NZ Herald newspaper
  • Subscribe to Herald Premium
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Bay of Plenty Times
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven Car Guide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP